Personalis, Inc.
NASDAQ:PSNL
4.32 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Personalis, Inc. |
Symbool | PSNL |
Munteenheid | USD |
Prijs | 4.32 |
Beurswaarde | 229,282,704 |
Dividendpercentage | 0% |
52-weken bereik | 0.891 - 7.2 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Christopher M. Hall |
Website | https://www.personalis.com |
An error occurred while fetching data.
Over Personalis, Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)